AUTM on the Air

There’s a moment every tech transfer professional recognizes, when a discovery feels like it could matter, but you can’t quite see how it gets from the lab into the real world. Tha...

Collaboration is one of the defining strengths of the technology transfer community, and it often becomes even more important when resources are limited. This conversation takes a ...

Clean water plays a fundamental role in health, safety, and quality of life. This Earth Day conversation takes a closer look at PFAS, often called “forever chemicals,” and the grow...

Turning research into something that actually works in the real world sounds straightforward, but it rarely is. There’s a gap between discovery and impact that trips up even the mo...

One of the toughest calls in technology transfer isn’t deciding whether a discovery is interesting or even promising. It’s deciding whether that discovery should become a company a...

Some of the most meaningful industry–academic partnerships don’t begin with a breakthrough headline or a flashy piece of technology. More often, they take shape around a real resea...

Sometimes the most powerful innovations come from the most personal places. This episode tells the extraordinary story of Danyelza (naxitamab), a life-saving immunotherapy for chil...

If you've ever thought that intellectual property was just for lawyers, patent professionals, and the occasional venture capitalist, today's episode might change your mind. We're t...

If you've ever wondered what's actually going on inside a company's head when a university comes knocking with a new technology, today's episode is for you. We're getting into the ...

One of the biggest challenges in tech transfer isn't generating innovation — it's helping promising technologies move from early success into sustained, real-world use. That patter...

Policy conversations can feel distant until they land squarely on the desks of technology transfer professionals. Coming to you from the AUTM Annual Meeting in Seattle, we’re takin...

Breakthrough therapies do not begin with commercialization, yet without it, many breakthroughs never reach patients. That tension sits at the center of this conversation with Miche...